LOSS OF THE RENAL VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN II DURING RENAL ISCHEMIA.
D000804:Angiotensin II; D000809:Angiotensins; D001285:Atropine; D001783:Blood Flow Velocity; D001795:Blood Pressure Determination; D003714:Denervation; D004285:Dogs; D004837:Epinephrine; D007511:Ischemia; D007668:Kidney; D007674:Kidney Diseases; D009638:Norepinephrine; D010600:Pharmacology; D012039:Regional Blood Flow; D012106:Research; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D014666:Vasomotor System
D000809:Angiotensins; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D001285:Atropine; D009638:Norepinephrine; D004837:Epinephrine
ANGIOTENSIN; ATROPINE; BLOOD FLOW VELOCITY; BLOOD PRESSURE DETERMINATION; DENERVATION; DOGS; EPINEPHRINE; EXPERIMENTAL LAB STUDY; ISCHEMIA; KIDNEY; KIDNEY DISEASES; NOREPINEPHRINE; PHARMACOLOGY; REGIONAL BLOOD FLOW; SYMPATHOMIMETICS; VASOMOTOR SYSTEM